Literature DB >> 19520738

Vascular stasis, intestinal hemorrhage, and heightened vascular permeability complicate acute portal hypertension in cd39-null mice.

Xiaofeng Sun1, Andrés Cárdenas, Yan Wu, Keichi Enjyoji, Simon C Robson.   

Abstract

Vasoactive factors that regulate splanchnic hemodynamics include nitric oxide, catecholamines, and possibly extracellular nucleosides/nucleotides (adenosine, ATP). CD39/ectonucleoside triphosphate diphosphohydrolase-1 (NTPDase1) is the major vascular ectonucleotidase that hydrolyzes extracellular nucleotides. CD39 activity may be modulated by vascular injury, inflammation, and altered oxygen tension. Altered Cd39 expression by the murine hepatosplanchnic vasculature may impact hemodynamics and portal hypertension (PHT) in vivo. We noted that basal portal pressures (PPs) were comparable in wild-type and Cd39-null mice (n = 9). ATP infusions resulted in increments in PP in wild-type mice, but, in contrast, this significantly decreased in Cd39-null mice (n = 9) post-ATP in a nitric oxide-dependent manner. We then studied Cd39/NTPDase1 deletion in the regulation of portal hemodynamics, vascular integrity, and intestinal permeability in a murine model of PHT. Partial portal vein ligation (PPVL) was performed in Cd39-null (n = 44) and wild-type (n = 23) mice. Sequential measurements obtained after PPVL were indicative of comparable levels of PHT (ranges 14-29 mmHg) in both groups. There was one death in the wild-type group and eight in the Cd39-null group from intestinal bleeding (P = 0.024). Circulatory stasis in the absence of overt portal vein thrombosis, portal congestion, intestinal hemorrhage, and increased permeability were evident in all surviving Cd39-null mice. Deletion of Cd39 results in deleterious outcomes post-PPVL that are associated with significant microcirculatory derangements and major intestinal congestion with hemorrhage mimicking acute mesenteric occlusion. Absent Cd39/NTPDase1 and decreased generation of adenosine in the splanchnic circulation cause heightened vascular permeability and gastrointestinal hemorrhage in PPVL.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19520738      PMCID: PMC2724088          DOI: 10.1152/ajpgi.90703.2008

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  34 in total

Review 1.  Mesenteric venous thrombosis.

Authors:  S Kumar; M G Sarr; P S Kamath
Journal:  N Engl J Med       Date:  2001-12-06       Impact factor: 91.245

2.  Intestinal permeability in rats with CCl4-induced portal hypertension.

Authors:  Guo-Xiang Yao; Zhong-Yi Shen; Xin-Bo Xue; Zhen Yang
Journal:  World J Gastroenterol       Date:  2006-01-21       Impact factor: 5.742

3.  Increased angiogenesis and permeability in the mesenteric microvasculature of rats with cirrhosis and portal hypertension: an in vivo study.

Authors:  Anja M Geerts; An S De Vriese; Eline Vanheule; Hans Van Vlierberghe; Siska Mortier; Kin-Jip Cheung; Pieter Demetter; Norbert Lameire; Martine De Vos; Isabelle Colle
Journal:  Liver Int       Date:  2006-09       Impact factor: 5.828

4.  Intestinal permeability in liver cirrhosis: relationship with severe septic complications.

Authors:  B Campillo; P Pernet; P N Bories; J P Richardet; M Devanlay; C Aussel
Journal:  Eur J Gastroenterol Hepatol       Date:  1999-07       Impact factor: 2.566

5.  P2X(1) receptor-deficient mice establish the native P2X receptor and a P2Y6-like receptor in arteries.

Authors:  Catherine Vial; Richard J Evans
Journal:  Mol Pharmacol       Date:  2002-12       Impact factor: 4.436

6.  N-acetylcysteine prevents development of the hyperdynamic circulation in the portal hypertensive rat.

Authors:  B Fernando; R Marley; S Holt; R Anand; D Harry; P Sanderson; R Smith; G Hamilton; K Moore
Journal:  Hepatology       Date:  1998-09       Impact factor: 17.425

Review 7.  Endocannabinoids and liver disease. V. endocannabinoids as mediators of vascular and cardiac abnormalities in cirrhosis.

Authors:  Leila Moezi; Seyed Ali Gaskari; Samuel S Lee
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-08-14       Impact factor: 4.052

8.  Effects of tumor necrosis factor, endothelin and nitric oxide on hyperdynamic circulation of rats with acute and chronic portal hypertension.

Authors:  Ji-Jian Wang; Gen-Wu Gao; Ren-Zhong Gao; Chang-An Liu; Xiong Ding; Zhen-Xiang Yao
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

9.  Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice.

Authors:  Mercedes Fernandez; Francesco Vizzutti; Juan Carlos Garcia-Pagan; Juan Rodes; Jaime Bosch
Journal:  Gastroenterology       Date:  2004-03       Impact factor: 22.682

10.  Proinflammatory liver and antiinflammatory intestinal mediators involved in portal hypertensive rats.

Authors:  Maria Angeles Aller; Elena Vara; Cruz Garcia; Maria Dolores Palma; Jorge L Arias; Maria Paz Nava; Jaime Arias
Journal:  Mediators Inflamm       Date:  2005-06-09       Impact factor: 4.711

View more
  3 in total

1.  Role of purinergic P2X receptors in the control of liver homeostasis.

Authors:  Michel Fausther; Emmanuel Gonzales; Jonathan A Dranoff
Journal:  Wiley Interdiscip Rev Membr Transp Signal       Date:  2012-01-11

2.  Loss of vascular expression of nucleoside triphosphate diphosphohydrolase-1/CD39 in hypertension.

Authors:  Charlotte Roy; Julie Tabiasco; Antoine Caillon; Yves Delneste; Jean Merot; Julie Favre; Anne Laure Guihot; Ludovic Martin; Daniele C Nascimento; Bernhard Ryffel; Simon C Robson; Jean Sévigny; Daniel Henrion; Gilles Kauffenstein
Journal:  Purinergic Signal       Date:  2017-12-13       Impact factor: 3.765

Review 3.  Cellular function and molecular structure of ecto-nucleotidases.

Authors:  Herbert Zimmermann; Matthias Zebisch; Norbert Sträter
Journal:  Purinergic Signal       Date:  2012-05-04       Impact factor: 3.765

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.